ADiTx Therapeutics, Inc. Business Finance Contracts & Agreements
141 Contracts & Agreements
- Assignment Agreements (4 contracts)
- Credit Agreements (9)
- Exchange Agreements (5)
- Investment Agreements (2)
- Loan Agreements (6)
- Note Agreements (30)
- Purchase Agreements (21)
- Registration Rights Agreements (7)
- Security Agreements (12)
- Stock Agreements (2)
- Subscription Agreements (1)
- Underwriting Agreements (6)
- Waiver Agreements (2)
- Warrant Agreements (34)
- Form of Amendment No. 4 to January 2024 Secured Notes (Filed With SEC on February 29, 2024)
- Assignment Agreement dated as of February 26, 2024 (Filed With SEC on February 29, 2024)
- Unsecured Promissory Note dated February 15, 2024 (Filed With SEC on February 16, 2024)
- Form of Unsecured Promissory Note dated February 7, 2024 (Filed With SEC on February 9, 2024)
- Form of Amendment No. 2 to September 2024 Secured Notes (Filed With SEC on February 6, 2024)
- Form of Amendment No. 3 to January 2024 Secured Notes (Filed With SEC on February 6, 2024)
- Patent Assignment dated January 24, 2024 (Filed With SEC on January 30, 2024)
- Form of Securities Purchase Agreement dated January 24, 2024 (Filed With SEC on January 30, 2024)
- Assignment Agreement dated January 24, 2024 (Filed With SEC on January 30, 2024)
- Form of Business Loan and Security Agreement dated January 24, 2024 (Filed With SEC on January 30, 2024)
- First Amendment to Asset Purchase Agreement dated January 4, 2024 by and among Aditxt, Inc., Pearsanta, Inc., and MDNA Life Sciences, Inc (Filed With SEC on January 9, 2024)
- Form of Company Warrant (Filed With SEC on January 9, 2024)
- Form of Amendment No. 1 to September 2024 Secured Notes (Filed With SEC on January 5, 2024)
- Form of Amendment No. 2 to January 2024 Secured Notes (Filed With SEC on January 5, 2024)
- Form of Amendment No. 1 to January 2024 Secured Notes (Filed With SEC on January 5, 2024)
- Form of Registration Rights Agreement (Filed With SEC on January 5, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on January 5, 2024)
- Form of Placement Agent Warrant (Filed With SEC on January 5, 2024)
- Form of Common Warrant (Filed With SEC on January 5, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on January 5, 2024)
- Exchange Agreement, dated December 28, 2023 by and between the Company and the holders signatory thereto (Filed With SEC on January 2, 2024)
- Registration Rights Agreement, dated December 22, 2023 by and between the Company and the holders signatory thereto (Filed With SEC on December 26, 2023)
- Exchange Agreement, dated December 22, 2023 by and between the Company and the holders signatory thereto (Filed With SEC on December 26, 2023)
- Form of Unsecured Promissory Note dated December 20, 2023 (Filed With SEC on December 22, 2023)
- Asset Purchase Agreement by and among Aditxt, Inc., Pearsanta, Inc. and MDNA Life Sciences, Inc. dated as of December 17, 2023 (Filed With SEC on December 21, 2023)
- Security Agreement dated December 11, 2023 (Filed With SEC on December 12, 2023)
- IP Security Agreement dated December 11, 2023 (Filed With SEC on December 12, 2023)
- Form of Royalty Note (Filed With SEC on December 12, 2023)
- Form of September 2024 Secured Note (Filed With SEC on December 12, 2023)
- Form of December 2023 Secured Note (Filed With SEC on December 12, 2023)
- Assignment Agreement dated as of December 11, 2023 (Filed With SEC on December 12, 2023)
- Form of Unsecured Promissory Note (Filed With SEC on December 8, 2023)
- Form of Unsecured Promissory Note (Filed With SEC on December 1, 2023)
- Form of Business Loan and Security Agreement dated November 7, 2023 (Filed With SEC on November 9, 2023)
- Form of Agreement for the Purchase and Sale of Future Receipts (Filed With SEC on October 11, 2023)
- Form of Registration Rights Agreement (Filed With SEC on September 6, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on September 6, 2023)
- Form of Placement Agent Warrant (Filed With SEC on September 6, 2023)
- Form of Warrant (Filed With SEC on September 6, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on September 6, 2023)
